{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:38:37Z","timestamp":1784893117321,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Female Pelvic Med Reconstr Surg"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aims of this study were to determine the proportion of women presenting for recurrent urinary tract infections (UTIs) who met the diagnostic criteria (culture-proven UTI \u22653 in 1 year or \u22652 in 6 months) and to assess advanced testing utilization, preventive therapy use, and risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective chart review of women seen as new urogynecology consults for recurrent UTI (rUTI) between April 1, 2017, and April 1, 2018, followed through April 1, 2019. Exclusion criteria included catheter use, cancer treatment within 2 years, and prior organ transplant, urinary diversion, conduit, or bladder augmentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 600 women, 71% had follow-up with a median of 179 days. Urinary tract infection symptoms included frequency (50%), dysuria (46%), urgency (43%), and malodorous urine (7%). One third met the rUTI diagnostic criteria. Two hundred thirty-four (39%) underwent advanced testing, and 9% (21\/234) of women who underwent advanced testing had a change in clinical care. Preventive therapy use increased after consultation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), with vaginal estrogen (47%) being most common. Compared with women not meeting the rUTI criteria, women meeting the rUTI criteria were more likely to be older (adjusted odds ratio [aOR], 1.03\/year; 95% confidence interval [CI], 1.02\u20131.04), have a prior history of gynecologic cancer (aOR, 4.07; 95% CI, 1.02\u201316.25), or report UTI symptoms of dysuria (aOR, 2.27; 95% CI, 1.57\u20133.27), or malodorous urine (aOR, 2.96; 95% CI, 1.47\u20135.94) and, while equally likely to be receiving preventive treatment prior to consultation, were more likely after consultation (OR, 3.06; 95% CI, 2.05\u20134.55).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Thirty-seven percent of women seen for rUTI met the diagnostic criteria. Advanced imaging rarely changed care. Education about diagnostic criteria and preventive therapy is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spv.0000000000001065","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T14:01:46Z","timestamp":1619618506000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Baseline Characteristics, Evaluation, and Management of Women With Complaints of Recurrent Urinary Tract Infections"],"prefix":"10.1097","volume":"27","author":[{"given":"Alexis A.","family":"Dieter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret G.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uduak U.","family":"Andy","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Pelvic Reconstructive Surgery, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Kirby","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denicia S.","family":"Dwarica","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, University of Missouri, Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy L.","family":"Amundsen","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Reconstructive Pelvic Surgery, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Thomas","family":"Gregory","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Reconstructive Pelvic Surgery, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Desai","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Reconstructive Pelvic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Clayton","sequence":"additional","affiliation":[{"name":"Trinity Health of New England, Hartford, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Squires","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Allen","sequence":"additional","affiliation":[{"name":"Division of Urogynecology and Pelvic Reconstructive Surgery, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn P.","family":"Casper","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"University of Missouri School of Medicine, Columbia MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Trinity Health of New England, Hartford, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20260610","article-title":"Clinical presentations and epidemiology of urinary tract infections","volume":"4","year":"2016","journal-title":"Microbiol Spectr"},{"key":"bib2-20260610","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","year":"2013","journal-title":"BMJ"},{"key":"bib3-20260610","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","year":"2000","journal-title":"Ann Epidemiol"},{"key":"bib4-20260610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urology.2019.01.031","article-title":"Financial burden of recurrent urinary tract infections in women: a time-driven activity-based cost analysis","volume":"128","year":"2019","journal-title":"Urology"},{"key":"bib5-20260610","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14737167.2017.1359543","article-title":"Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)","volume":"18","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"bib6-20260610","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.juro.2018.04.088","article-title":"Treatment and prevention of recurrent lower urinary tract infections in women: a rapid review with practice recommendations","volume":"200","year":"2018","journal-title":"J Urol"},{"key":"bib7-20260610","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/JU.0000000000000296","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","year":"2019","journal-title":"J Urol"},{"key":"bib8-20260610","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPV.0000000000000550","article-title":"American Urogynecologic Society best-practice statement: recurrent urinary tract infection in adult women","volume":"24","year":"2018","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"bib9-20260610","first-page":"316","article-title":"Guidelines for the diagnosis and management of recurrent urinary tract infection in women","volume":"5","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"bib10-20260610","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/ciz021","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","year":"2019","journal-title":"Clin Infect Dis"},{"key":"bib11-20260610","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","year":"2019","journal-title":"J Biomed Inform"},{"key":"bib12-20260610","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"bib13-20260610","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2014.303","article-title":"Urinary tract infections in older women: a clinical review","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"bib14-20260610","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.287.20.2701","article-title":"Does this woman have an acute uncomplicated urinary tract infection?","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"bib15-20260610","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"bib16-20260610","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ijgc-2019-001034","article-title":"Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma","volume":"30","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"bib17-20260610","article-title":"Evaluating the role of urinalysis for suspected cystitis in women undergoing pelvic radiotherapy [published online April 21, 2016]","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"bib18-20260610","doi-asserted-by":"crossref","first-page":"e1388","DOI":"10.6061\/clinics\/2019\/1388","article-title":"Urinary infection or radiation cystitis? A prospective evaluation of urinary symptoms in patients submitted to pelvic radiotherapy","volume":"74","year":"2019","journal-title":"Clinics (Sao Paulo)"},{"key":"bib19-20260610","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/515209","article-title":"Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections","volume":"28","year":"1999","journal-title":"Clin Infect Dis"},{"key":"bib20-20260610","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"ACOG committee opinion no. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"bib21-20260610","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/01.AOG.0000428645.90795.d9","article-title":"ACOG committee opinion no. 556: postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism","volume":"121","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["Female Pelvic Medicine &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000001065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:00:51Z","timestamp":1781092851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/spv.0000000000001065","relation":{},"ISSN":["2151-8378","2154-4212"],"issn-type":[{"value":"2151-8378","type":"print"},{"value":"2154-4212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}